References
1. Siegel DA, Richardson LC, Henley SJ, et al. Pediatric cancer mortality and survival in the United States, 2001‐2016. Cancer . 2020;126(19):4379-4389. doi:10.1002/cncr.33080
2. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. Longo DL, ed. N Engl J Med . 2015;373(16):1541-1552. doi:10.1056/NEJMra1400972
3. Cusinato M, Calvo V, Bisogno G, et al. Attachment orientations and psychological adjustment of parents of children with cancer: A matched-group comparison. Journal of Psychosocial Oncology . 2017;35(6):726-740. doi:10.1080/07347332.2017.1335365
4. Brinkman TM, Recklitis CJ, Michel G, Grootenhuis MA, Klosky JL. Psychological Symptoms, Social Outcomes, Socioeconomic Attainment, and Health Behaviors Among Survivors of Childhood Cancer: Current State of the Literature. J Clin Oncol . 2018;36(21):2190-2197. doi:10.1200/JCO.2017.76.5552
5. Kazak AE, Noll RB. The integration of psychology in pediatric oncology research and practice: Collaboration to improve care and outcomes for children and families. American Psychologist . 2015;70(2):146-158. doi:10.1037/a0035695
6. Maruff P, Thomas E, Cysique L, et al. Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex. Archives of Clinical Neuropsychology . 2009;24(2):165-178. doi:10.1093/arclin/acp010
7. Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust . (Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, eds.). National Academies Press (US); 2011. Accessed May 24, 2023. http://www.ncbi.nlm.nih.gov/books/NBK209539/
8. Robinson PD, Oberoi S, Tomlinson D, et al. Management of fatigue in children and adolescents with cancer and in paediatric recipients of haemopoietic stem-cell transplants: a clinical practice guideline.Lancet Child Adolesc Health . 2018;2(5):371-378. doi:10.1016/S2352-4642(18)30059-2
9. Guidelines on the Management of Chronic Pain in Children . World Health Organization; 2020. Accessed May 24, 2023. http://www.ncbi.nlm.nih.gov/books/NBK566553/
10. Seelisch J, Sung L, Kelly MJ, et al. Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children’s Oncology Group. Pediatr Blood Cancer . 2019;66(1):e27471. doi:10.1002/pbc.27471
11. Schulte F, Kunin-Batson AS, Olson-Bullis BA, et al. Social attainment in survivors of pediatric central nervous system tumors: a systematic review and meta-analysis from the Children’s Oncology Group.J Cancer Surviv . 2019;13(6):921-931. doi:10.1007/s11764-019-00808-3
12. Devine KA, Christen S, Mulder RL, et al. Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent, and young adult cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Cancer . 2022;128(13):2405-2419. doi:10.1002/cncr.34215
13. Gilleland Marchak J, Devine KA, Hudson MM, et al. Systematic Review of Educational Supports of Pediatric Cancer Survivors: Current Approaches and Future Directions. J Clin Oncol . 2021;39(16):1813-1823. doi:10.1200/JCO.20.02471
14. Marchak JG, Christen S, Mulder RL, et al. Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol . 2022;23(4):e184-e196. doi:10.1016/S1470-2045(21)00750-6
15. Christen S, Roser K, Mulder RL, et al. Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. J Cancer Surviv . 2020;14(6):923-938. doi:10.1007/s11764-020-00904-9
16. Schulte FSM, Patton M, Alberts NM, et al. Pain in long-term survivors of childhood cancer: A systematic review of the current state of knowledge and a call to action from the Children’s Oncology Group.Cancer . 2021;127(1):35-44. doi:10.1002/cncr.33289
17. Close AG, Dreyzin A, Miller KD, Seynnaeve BKN, Rapkin LB. Adolescent and young adult oncology-past, present, and future. CA Cancer J Clin . 2019;69(6):485-496. doi:10.3322/caac.21585
18. Roth ME, Parsons SK, Ganz PA, et al. Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials. J Natl Cancer Inst . 2023;115(1):21-28. doi:10.1093/jnci/djac166
19. Cherven B, Sampson A, Bober SL, et al. Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children’s Oncology Group Adolescent and Young Adult Oncology Discipline Committee. CA Cancer J Clin . 2021;71(3):250-263. doi:10.3322/caac.21655
20. Frederick NN, Bingen K, Bober SL, et al. Pediatric oncology clinician communication about sexual health with adolescents and young adults: A report from the children’s oncology group. Cancer Med . 2021;10(15):5110-5119. doi:10.1002/cam4.4077
21. Noone A, Howlander N, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2015. SEER. Published 2018. Accessed May 24, 2023. https://seer.cancer.gov/archive/csr/1975_2015/index.html
22. Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol . 2013;50(3):185-196. doi:10.1053/j.seminhematol.2013.06.007
23. van der Plas E, Modi AJ, Li CK, Krull KR, Cheung YT. Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only. J Clin Oncol . 2021;39(16):1705-1717. doi:10.1200/JCO.20.02322
24. Johnson SB, Riis JL, Noble KG. State of the Art Review: Poverty and the Developing Brain. Pediatrics . 2016;137(4):e20153075. doi:10.1542/peds.2015-3075
25. Hasle H. Pattern of malignant disorders in individuals with Down’s syndrome. Lancet Oncol . 2001;2(7):429-436. doi:10.1016/S1470-2045(00)00435-6
26. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down’s syndrome. Lancet . 2000;355(9199):165-169. doi:10.1016/S0140-6736(99)05264-2
27. Athale UH, Puligandla M, Stevenson KE, et al. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001. Pediatr Blood Cancer . 2018;65(10):e27256. doi:10.1002/pbc.27256
28. Buitenkamp TD, Izraeli S, Zimmermann M, et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood . 2014;123(1):70-77. doi:10.1182/blood-2013-06-509463
29. Kutny MA, Alonzo TA, Abla O, et al. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children’s Oncology Group AAML1331 Trial. JAMA Oncol . 2022;8(1):79. doi:10.1001/jamaoncol.2021.5206
30. Tolins M, Ruchirawat M, Landrigan P. The Developmental Neurotoxicity of Arsenic: Cognitive and Behavioral Consequences of Early Life Exposure. Annals of Global Health . 2014;80(4):303-314. doi:10.1016/j.aogh.2014.09.005
31. Vaidya N, Holla B, Heron J, et al. Neurocognitive Analysis of Low-level Arsenic Exposure and Executive Function Mediated by Brain Anomalies Among Children, Adolescents, and Young Adults in India.JAMA Netw Open . 2023;6(5):e2312810. doi:10.1001/jamanetworkopen.2023.12810
32. Knipp S, Gattermann N, Schapira M, Käferstein H, Germing U. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.Leukemia Research . 2007;31(11):1585-1587. doi:10.1016/j.leukres.2007.03.007
33. Au WY, Tam S, Fong BM, Kwong YL. Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood . 2008;112(9):3587-3590. doi:10.1182/blood-2008-06-161000
34. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood.Lancet Oncol . 2004;5(7):399-408. doi:10.1016/S1470-2045(04)01507-4
35. Pellegrini JW, Lipton SA. Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol . 1993;33(4):403-407. doi:10.1002/ana.410330414
36. Liu C, Lin N, Wu B, Qiu Y. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res . 2009;1282:173-182. doi:10.1016/j.brainres.2009.05.071
37. Brown PD, Pugh S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol . 2013;15(10):1429-1437. doi:10.1093/neuonc/not114
38. Santacroce SJ, Kneipp SM. A Conceptual Model of Financial Toxicity in Pediatric Oncology. J Pediatr Oncol Nurs . 2019;36(1):6-16. doi:10.1177/1043454218810137
39. Tran YH, Coven SL, Park S, Mendonca EA. Social determinants of health and pediatric cancer survival: A systematic review. Pediatr Blood Cancer . 2022;69(5):e29546. doi:10.1002/pbc.29546
40. Pelletier W, Bona K. Assessment of Financial Burden as a Standard of Care in Pediatric Oncology. Pediatr Blood Cancer . 2015;62 Suppl 5:S619-631. doi:10.1002/pbc.25714
41. Aristizabal P, Winestone LE, Umaretiya P, Bona K. Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer. Am Soc Clin Oncol Educ Book . 2021;41:e315-e326. doi:10.1200/EDBK_320499
42. Scheurer ME, Lupo PJ, Schüz J, et al. An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatric Hematology and Oncology . 2018;35(2):95-110. doi:10.1080/08880018.2018.1464088
43. Gupta S, Wilejto M, Pole JD, Guttmann A, Sung L. Low socioeconomic status is associated with worse survival in children with cancer: a systematic review. PLoS One . 2014;9(2):e89482. doi:10.1371/journal.pone.0089482
44. Bhatia S. Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer . 2011;56(6):994-1002. doi:10.1002/pbc.23078
45. Gupta S, Teachey DT, Devidas M, et al. Racial, Ethnic, and Socioeconomic Factors Result in Disparities in Outcome Among Children with Acute Lymphoblastic Leukemia Not Fully Attenuated By Disease Prognosticators: A Children’s Oncology Group (COG) Study. Blood . 2021;138(Supplement 1):211-213. doi:10.1182/blood-2021-147386
46. Newman H, Lee S, Pölönen P, et al. The Influence of Genetic Ancestry on Disease Biology in Pediatric T-Cell Acute Lymphoblastic Leukemia.Blood . 2022;140(Supplement 1):3458-3460. doi:10.1182/blood-2022-159159
47. Kelada L, Wakefield CE, Vetsch J, et al. Financial toxicity of childhood cancer and changes to parents’ employment after treatment completion. Pediatr Blood Cancer . 2020;67(7):e28345. doi:10.1002/pbc.28345
48. Umaretiya PJ, Koch VB, Stevenson KE, et al. Household material hardship and parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia. JCO . 2021;39(15_suppl):10025-10025. doi:10.1200/JCO.2021.39.15_suppl.10025
49. Ilowite MF, Al-Sayegh H, Ma C, et al. The Relationship Between Household Income and Patient-Reported Symptom Distress and Quality of Life in Children With Advanced Cancer: A Report From the PediQUEST Study. Cancer . 2018;124(19):3934-3941. doi:10.1002/cncr.31668
50. Bona K, Keating NL. Addressing Social Determinants of Health: Now Is the Time. JNCI: Journal of the National Cancer Institute . 2022;114(12):1561-1563. doi:10.1093/jnci/djac137
51. Aziz-Bose R, Zheng DJ, Umaretiya PJ, et al. Feasibility of oncology clinical trial-embedded evaluation of social determinants of health.Pediatr Blood Cancer . 2022;69(11):e29933. doi:10.1002/pbc.29933
52. Beauchemin M, Santacroce SJ, Bona K, et al. Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States.BMC Health Services Research . 2022;22(1):832. doi:10.1186/s12913-022-08201-0